Loading provider…
Loading provider…
Ophthalmology Physician in Gilroy, CA
NPI: 1083803621Primary Employer
Scvmc Physician Services
hhs.sccgov.org
HQ Phone
Get MD Carolyn's Phone Numberphone_androidMobile
Get MD Carolyn's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2011 - 2026
CO State Medical License
2008 - 2011
OH State Medical License
2007 - 2008

American Board of Ophthalmology
Ophthalmology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Surgical Retina and Vitreous
2011 - 2013
University of Colorado
Residency • Ophthalmology
2008 - 2011
Jewish Hospital of Cincinnati
Internship • Internal Medicine
2007 - 2008
Wayne State University School Of Medicine
med.wayne.edu
Medical School
Until 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 156 | 329 |
| 2 | 67028Injection of drug into eye | 64 | 181 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 48 | 61 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 41 | 43 |
| 5 | 92012Eye and medical examination for diagnosis and treatment, established patient | 37 | 40 |
The Effect of Obstructive Sleep Apnea on Absolute Risk of Central Serous Chorioretinopathy.
Authors: Prithvi Mruthyunjaya, Daniel Vail
Publication Date: 2020-03-09
Authors: Diana Do, Connie Sears, Andrea Kossler, Chase Ludwig, Arthika Chandramohan, Tatiana Rosenblatt, Malini Pasricha
Journal: J Vitreoretin Dis
Publication Date: 2021-07-09
Authors: Prithvi Mruthyunjaya, Nadim Rayess, Michelle Cao
Journal: J Vitreoretin Dis
Publication Date: 2021-05-18
Lead Sponsor: Regeneron Pharmaceuticals
Collaborators: Bayer
Intervention / Treatment: DRUG: Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321), PROCEDURE: Macular Laser Photocoagulation